Independence Bank of Kentucky’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,036
Closed -$301K 381
2019
Q3
$301K Hold
3,036
0.21% 100
2019
Q2
$281K Sell
3,036
-175
-5% -$16.6K 0.22% 92
2019
Q1
$303K Sell
3,211
-235
-7% -$20.6K 0.25% 83
2018
Q4
$221K Sell
3,446
-4,080
-54% -$301K 0.2% 94
2018
Q3
$674K Buy
7,526
+1,790
+31% +$158K 0.53% 49
2018
Q2
$456K Sell
5,736
-2,265
-28% -$188K 0.38% 62
2018
Q1
$714K Buy
8,001
+2,126
+36% +$204K 0.61% 49
2017
Q4
$613K Buy
+5,875
New +$663K 0.52% 53

Other funds holding CELG

Independence Bank of Kentucky's CELG Position: Q4 2019 in Review

Independence Bank of Kentucky sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,036 shares — an estimated $301K sold.

Independence Bank of Kentucky first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $714K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Independence Bank of Kentucky reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Independence Bank of Kentucky sold 3,036 Celgene Corp shares in Q4 2019, an estimated $301K.
  • Independence Bank of Kentucky first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Independence Bank of Kentucky's Celgene Corp position peaked at $714K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Independence Bank of Kentucky's 13F filing for Q4 2019, filed 31 Jan 2020.